Abstract
Substance dependence is recognized in the scientific community to be a medical condition rather than a willful misbehavior, but in societies and in politics a connotation of moral weakness, of irresponsible behavior or even of criminal intent can be observed, in attitudes and arguments and in a stigmatization of addictive behavior. Therefore, treatment of substance dependence must respect both the individual and the societal values at stake, in designing and implementing therapeutic approaches, avoiding neglect as well as undue coercion. The empirical evidence on what can be achieved, for whom and under what circumstances, is the basis of treatment, in line with the principles of consequential ethics, of human rights and of medical ethics in general. Also, health policy has to minimize the risk factors for and the negative consequences of substance dependence, besides risk factors for and the negative consequences of substance dependence, besides providing treatment and care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMA:
-
American Medical Association
- APA:
-
American Psychiatric Association
- DATOS:
-
Drug Abuse Treatment Outcome Study
- DSM-IV:
-
Diagnostic-Statistical Manual of Mental Disorders, 4th revision (APA)
- EC:
-
European Commission
- EMCDDA:
-
European Monitoring Centre on Drugs and Drug Addiction
- EU:
-
European Union
- HIV:
-
Human Immunodeficiency Virus
- ICD-10:
-
International Classification of Diseases, 10th revision (WHO)
- NIDA:
-
National Institute of Drug Abuse
- NTIES:
-
National Treatment Improvement Evaluation Study
- NTORS:
-
National Treatment Outcome Research Study
- QCT:
-
Quasi-Compulsory Treatment
- UN:
-
United Nations
- UNODC:
-
United Nations Office on Drugs and Crime
- WHO:
-
World Health Organisation
References
AMA (2001) Principles of medical ethics. In: Code of medical ethics. American Medical Association, Chicago
Arif A, Westermeyer J (1990) Methadone maintenance in the management of opioid dependence. An international review. Praeger, New York, NY
Bergmark A (2008) Specific and contextual treatment mechanisms. Nordic Stud Alcohol Drugs 25:277–285
Broadhead RS, Kerr TH, Grund JPC, Altice FL (2002) Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues 32:329–356
Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS (2007) Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 11:1–171
Council of Europe (1950). Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine
Czuchry M, Dansereau DF (2005) Using motivational activities to facilitate treatment involvement and reduce risk. J Psychoactive Drugs 37:7–13
Department of Health (2002) Models of care for substance misuse treatment. Promoting quality, efficiency and effectiveness in drug misuse treatment services. Department of Health, London
Dijkgraf MGW, van der Zanden BP, de Borgie AJM, Blanken P, van Ree JM, van den Brink W (2005) Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. Br Med J 330:1297–1303
Dole VP, Nyswander ME (1965) A medical treatment for diacetyl-morphine (heroin) addiction. JAMA 193:646–650
EC (2008). Communication from the commission to the European parliament and council on an EU drugs action plan for 2009–2012. Commission of the European Communities COM(2008) 567/4, Brussels
Edlin BR, Keal KH, Lorwock J, Kral AH, Ciccarone DH, Moore LD, Lo B (2001) Is it justifiable to withhold treatment for hepatitis C from illicit drug users? New Engl J Med 345:211–215
Edwards G, Arif A (1980). Dug problems in a socio-cultural context. A basis for policy and programme planning. Public Health Papers no. 73, World Health Organisation, Geneva
Ekendahl M (2007) Will and Skill – an exploratory study of substance abuser’s attitudes towards life-style changes. Eur Addict Res 13:148–155
Elliot HM (1920) Memoirs of Jahangir. Islamic Book Service, Lahore
EU (2005). EU drug action plan. Amtsblatt der Europäischen Union 2005/C168/01, Brussels
EU (2008) Health programme 2008–2013. European Commission, DG Health and Consumer Protection, Brussels
EMCDDA (2007) EU drug action plan, progress report 2006. European Monitoring Centre on Drugs and Drug Addiction, Lisbon
Farrell M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D, Gossop M, Strang J (2004) Methadone maintenance treatment in opiate dependence: a review. Br Med J 309:997–1001
Fireman M, Rabkin JM (2001) Outcome of liver transplantation in patients with alcohol and other chemical dependence. Psychosomatics 42:172–173
Freud S (1885) Über die Allgemeinwirkung des Cocaïnes. Medizinisch-chirrgischer Centralblatt 32:374–375
Gerdner A (1998). Patient and programme factors with impact on outcome in Swedish compulsory care of addicts: a systematic review. Lund University
Gerstein DR, Datta AR, Ingels JS, Johnson RA, Rasinski KA, Schildhaus S, Talley K (1997). NTIES. The National Treatment Improvement Evaluation Study. Final Report. National Opinion Research Center, Chicago
Gossop M, Marsden J, Stewart D, Kidd T (2003) The national treatment outcome research study (NTORS): 4–5 year follow-up results. Addiction 98:291–303
Gossop M (2006) Treating drug misuse problems: evidence of effectiveness. National Treatment Agency for Substance Misuse, London
Gossop M, Stewart D, Marsden J (2007) Readiness for change and drug use outcomes after treatment. Addiction 102:301–308
Gruber J, Koszegi B (2001) Is addiction rational? Theory and evidence. Q J Econ 116:1261–1303
Harding G (2008) Constructing addiction as a moral failing. Sociol Health Illn 1:75–85
Hare R (1991) The philosophical basis of psychiatric ethics. In: Bloch S, Chodoff P (eds) Psychiatric ethics. Oxford University Press, Oxford
Health Canada (2008) Literature review – methadone maintenance treatment. Public Works and Government Services Canada, Ottawa
Hedrich D (2004) European report on drug consumption rooms. European Monitoring Centre on Drugs and Drug Addiction, Lisbon
Hiller ML, Knight K, Leukefeld C, Simpson DD (2002) Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment. Crim Justice Behav 29:56–75
Hubbard RL, Craddock SG, Anderson J (2003) Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 25:126–134. http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?PrId=3048&itool=AbstractPlus-def&uid=14670518&db=pubmed&url=http://linkinghub.elsevier.com/retrieve/pii/S0740547203001302
International Union for Health Promotion and Education (2000) The evidence of health promotion effectiveness: shaping public health in a new Europe. Part two, evidence book. European Commission and IUHPE, Brussels
Jellinek EM (1960) The disease concept of alcoholism. Hillhouse, New Haven, CT
Jonas H (1984) The imperative of responsibility. In search of ethics for the technological age. University of Chicago Press, Chicago
Kaya CY, Tugai Y, Filar JA, Agrawal MR, Ali RL, Gowing LR, Cooke R (2004) Heroin users in Australia: population trends. Drug Alcohol Rev 23:107–116
Klingemann H, Sobell LC (2007) Promoting self-change from addictive behaviors. Practical implications for policy, prevention and treatment. Springer, New York, NY
Kramer JC (1977) Heroin in the treatment of morphine addiction. J Psychedelic Drugs 197:193–197
Leshner A (1997) Addiction is a brain disease, and it matters. Science 278:45–47
Levine HG (1981) Mässigkeitsbewegung und Prohibition in den USA. In: Völger G (Hrsg) Rausch und Realität. Drogen im Kulturvergleich. Rautenstrauch-Joest-Museum, Köln, pp 126–131
Longabaugh RH, Wirtz PW (eds) (2001) Project MATCH hypotheses. Results and causal chain analyses. NIAAA project MATCH monograph series, vol 8. National Institute on Alcohol and Alcohol Abuse, Rockville, MD
Loose R (2005) The subject of addiction. Psychoanalysis and the Administration of Enjoyment, Sage, London
Marsh KL, Joe GW, Simpson DD, Lehmann WEK (1990) Treatment history. In: Simpson DD, Sells SB (eds) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malabar, pp 137–156
Mattick RP, Breen C, Kimber J, Davoli M, Breen R (2003) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev (2):CD002209
McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O’Brien CP (1997) Problem-service ‘matching’ in addiction treatment. A prospective study in 4 programs. Arch Gen Psychiatry 54:730–735
Merkx MJ, Schippers GM, Koeter MW, Oudejans S, Vujik PJ, Vries de CQ et al (2007) Allocation of substance use disorder patients to appropriate levels of care: feasibility of matching guidelines in routine practice in Dutch treatment centres. Addiction 102:466–474
Metzger DS, Woody GE, McLellan AT (1993) Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 6:1049–1056
Mill JS (1861) In: Robson JM (ed) Utilitarianism, Chapter 4. Collected works, vol 10, pp 203–259. Toronto University Press, Toronto, p 1963ff
Miller N, Flaherty JA (2000) Effectiveness of coerced addiction treatment (alternative consequences) a review of the clinical research. J Subst Abuse Treat 18:9–16
Miller WR, Rollnick S (2002) Motivational interviewing: preparing people for change. The Guilford Press, New York, NY
Moeller L, Stoever H, Juergens R, Gatherer A, Nikogosian H (eds) (2007) Health in prisons. A WHO guide to the essentials in prison health. World Health Organisation, Regional Office for Europe, Copenhagen
Moyer A, Finney JW, Swearingen CE, Vergun P (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations into treatment-seeking and non-treatment-seeking populations. Addiction 97:279–292
NIDA (1999) Principles of drug addiction treatment. A research-based guide. National Institute of Drug Abuse, Bethesda, MD
Parker T (1940) Transcendentalism. In: Muelder WG, Sears L (eds) The development of American philosophy. Houghton Mifflin, Boston, MA, pp 130–139
Prochaska JO, DiClemente CC (1982) Transtheoretical therapy: toward a more integrative model of change. Psychother: Theory Res Pract 19:276–288
Robins LN (1993) Vietnam veterans rapid recovery from heroin addiction – a fluke or normal expectation. Addiction 88:1041–1054
Rollnick S, Miller WR (1995) What is motivational interviewing? Behav Cogn Psychother 23:325–334
Room R (1980) Dependence and society. Br J Addiction 80:133–139
Room R, Janca A, Bennett L, Schmidt L, Sartorius N (1996) WHO cross-cultural applicability research on diagnosis and assessment of substance use disorders. Addiction 91:199–230
Rush B (1772) Sermons to gentleman. John Dunlap, Philadelphia, PA
Rust A (2000) Ethische Aspekte. In: Uchtenhagen A, Zieglgänsberger W (Hrsg) Suchtmedizin. Konzepte, Strategien und therapeutisches Management. Urban & Fischer, München, pp 573–584
Schippers GM, Schramade M, Walburg JA (2002) Reforming Dutch substance abuse treatment services. Addict Behav 27:995–1007
Schivelbusch W (1980) Das Paradies, der Geschmack und die Vernunft. Eine Geschichte der Genussmittel. Hanser, München
Schumacher JE, Milby JB, Wallace D, Meehan DC, Kertesz S, Vuchinich R, Dunning J, Usdan S (2007) Meta-analysis of day treatment and contingency-management dismantling research: Birmingham homeless cocaine studies (1990–2006). J Consult Clin Psychol 75:823–828
Single E, Collins D, Easton B, Harwood H, Lapsley H, Maynard A (1995) Proposed international guidelines for estimating the costs of substance abuse. Canadian Centre on Substance Abuse, Toronto, ON
Stallwitz A, Stoever H (2007) The impact of substitution treatment in prisons – a literature review. Int J Drug Policy 18:464–474
Stevens A, Hallam C, Trace M (2006a) Treatment for dependent drug use. A guide for policymakers. Beckley Foundation, London
Stevens A, Berto D, Frick U, Hunt N, Kerschl V, McSweeney T, Oeuvrey K, Puppo I, Santa Maria A, Schaaf S, Trinkl B, Uchtenhagen A, Werdenich W (2006b) The relationship between legal status, perceived pressure and motivation in treatment for drug dependence: results from a European study of quasi-compulsory treatment. Eur Addict Res 12:197–209
Stoever H, Hennebel JC, Casselmann J (2004) Substitution treatment in European prisons. A study in policies and practices of substitution in prisons in 18 European countries. Cranstoun Drug Services Publishing, London
Tännsjö T (1999) Coercive care. The ethics of choice in health and medicine. Routledge, London
Uchtenhagen A, Guggenbühl L (2000). Adequacy in drug abuse treatment and care in Europe (ADAT). Commissioned by World Health Organisation, Regional Office for Europe. Research Institute for Public Health and Addiction, Zurich
Uchtenhagen A (2003). Substitution management in opioid dependence. J Neurol Trans (Supplememt 66): Fleischhacker WW, Brooks DJ (eds) Addictions, mechanisms, phenomenology and treatment. pp 33–60
Uchtenhagen A (2004) Substance use problems in developing countries. Editorial, Bull World Health Org 82(9):641
Uchtenhagen A, Ladjevic T, Rehm J (2005). Guidelines for psychosocially assisted pharmacological treatment of persons dependent on opioids. Working paper for World Health Organisation. Research Institute for Public Health and Addiction, Zurich
Uchtenhagen A (2008) Heroin assisted treatment in Europe: a safe and effective approach. In: Stevens A (ed) Crossing frontiers. International developments in the treatment of drug dependence. Pavilion, Brighton, pp 53–82
UN (1948) The universal declaration of human rights. United Nations, New York, NY
UNODC (2008) Reducing the adverse health and social consequences of drug abuse: a comprehensive approach. United Nations Office on Drugs and Crime, Vienna
Volkow ND, Fowler JS, Wang GJ (2003) The addicted human brain: insights from imaging studies. J Clin Invest 111:1444–1451
Warner J (2007) Why abstinence matters to Americans. Editorial, Addiction 102:502–505
Weisner C (1990) Coercion in alcohol treatment. In: Institute of Medicine (ed) Broadening the base for the treatment of alcohol problems. The National Academic Press, Washington, DC, pp 579–610
Ward J, Mattick R, Hall W (1998) Methadone maintenance treatment an other opioid replacement therapies. Harwood, Amsterdam
West R (2006) Theory of addiction. Blackwell, Oxford
Westermeyer J (1982) Poppies, pipes and people: opium and it’s use in Laos. University of California Press, Berkeley
Westermeyer J (2006) The switch from opium to heroin smoking. Addiction 92:686–687
WHO (1986) The Ottawa charter for health promotion. World Health Organisation, Geneva
WHO (2001) The World Health Report 2001 – mental health, new understanding, new hope. World Health Organisation, Geneva
WHO (2004a) Proposal for the inclusion of methadone in the WHO model list of essential medicines. World Health Organisation, Geneva
WHO (2004b) Proposal for the inclusion of Buprenorphine in the WHO model list of essential medicines. World Health Organisation, Geneva
WHO (2008) Guidelines for the psychosocially supported pharmacological treatment of opioid dependence. World Health Organisation, Geneva
Wild DC, Cunningham JA, Ryan RM (2006) Social pressure, coercion, and client engagement at treatment entry: a self-determination theory perspective. Addict Behav 31:1858–1872
Zinberg NE (1984) Drug, set and setting. Yale University Press, New Haven, CT
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Uchtenhagen, A. (2010). Treatment of Substance Dependence. In: Helmchen, H., Sartorius, N. (eds) Ethics in Psychiatry. International Library of Ethics, Law, and the New Medicine, vol 45. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8721-8_23
Download citation
DOI: https://doi.org/10.1007/978-90-481-8721-8_23
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8720-1
Online ISBN: 978-90-481-8721-8
eBook Packages: MedicineMedicine (R0)